We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
3801
DELISTED
Apellis Pharmaceuticals
APLS
-46
Closed -$1.16K
APPF icon
3802
AppFolio
APPF
$8.3B
-236
Closed -$54.9K
AQST icon
3803
Aquestive Therapeutics
AQST
$630M
-7
Closed -$45
ARBK
3804
Argo Blockchain
ARBK
$42M
-1
Closed -$4
ARKB icon
3805
ARK 21Shares Bitcoin ETF
ARKB
$2.96B
-6
Closed -$167
ARRY icon
3806
Array Technologies
ARRY
$707M
-346
Closed -$3.19K
ASH icon
3807
Ashland
ASH
$3.41B
-78
Closed -$4.58K
ASPI icon
3808
ASP Isotopes
ASPI
$595M
-283
Closed -$1.51K
ATEX icon
3809
Anterix
ATEX
$1.81B
-89
Closed -$1.94K
ATHM icon
3810
Autohome
ATHM
$2.63B
-130
Closed -$2.89K
ATNM icon
3811
Actinium Pharmaceuticals
ATNM
$31.7M
-707
Closed -$962
ATOS icon
3812
Atossa Therapeutics
ATOS
$25.7M
-3
Closed -$25
ATRO icon
3813
Astronics
ATRO
$3.26B
-40
Closed -$1.79K
ATXS
3814
DELISTED
Astria Therapeutics
ATXS
-7
Closed -$92
AUR icon
3815
Aurora
AUR
$11.7B
-3,137
Closed -$12K
AVAH icon
3816
Aveanna Healthcare
AVAH
$2.91B
-6
Closed -$49
AVDL
3817
DELISTED
Avadel Pharmaceuticals
AVDL
-8
Closed -$172
AVIR icon
3818
Atea Pharmaceuticals
AVIR
$430M
-8
Closed -$29
AVLC icon
3819
Avantis US Large Cap Equity ETF
AVLC
$1.46B
-736
Closed -$57.8K
AVSU icon
3820
Avantis Responsible US Equity ETF
AVSU
$483M
-202
Closed -$15.4K
AWF
3821
AllianceBernstein Global High Income Fund
AWF
$876M
-200
Closed -$2.14K
AXGN icon
3822
Axogen
AXGN
$2.77B
-1,045
Closed -$34.2K
DCH
3823
Dauch Corp
DCH
$1.5B
-20
Closed -$128
BANF icon
3824
BancFirst
BANF
$3.71B
-58
Closed -$6.15K
BB icon
3825
BlackBerry
BB
$4.78B
-2,080
Closed -$7.88K

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.